Approaches to discovering, analyzing, and synthesizing compounds through automated in silico experimentation
AssigneeLigandal, Inc.
InventorsAndre WATSON, Adam STEIN, Nash RAIGLE
Life of this patent
Estimating the term…
Loading patent…
AssigneeLigandal, Inc.
InventorsAndre WATSON, Adam STEIN, Nash RAIGLE
Estimating the term…
Introduced here is an approach to developing molecules and molecule groups via a simulated mutagenesis process that is performed as part of in silico experimentation. Due to its initiation of the simulation based on a known binding interface or predicted binding interface between two structures—whether biological or synthetic—with known sequences, the approach introduced here can accomplish linear iteration of sequences. This can be accomplished whether these sequences relate to proteins, biological amino acids, synthetic amino acids, biological nucleic acids, synthetic nucleic acids, unnatural variants thereof, or any other molecules with a three-dimensional (“3D”) structure to evaluate the thermodynamic binding and affinity of the interaction as individual nucleic acids, amino acids or individual units of a polymer are mutated one at a time.
A computing device comprising:
A method for developing a peptide having a therapeutic application, the method comprising:
A non-naturally occurring peptide ligand of CD34 comprising or consisting of an amino acid sequence at least about 80%, 85%, 90%, 95%, 99%, or 100% identical to a sequence selected from the group consisting of SEQ ID NO:
13-182. (canceled)
Dependencies are inferred from the claim text.